Skip navigation


Current DateTime: 07:21:43 11 Feb 2012
LinksList Documentid: 23452764
Expiration DateTime: 2/11/2012 7:24:24 AM

Current DateTime: 07:21:44 11 Feb 2012
LinksList Documentid: 23452000
Expiration DateTime: 2/11/2012 7:24:40 AM

Current DateTime: 07:21:45 11 Feb 2012
LinksList Documentid: 24355697
  • The World's Best Beers

      Craft brewers account for only about five percent of the US market, but that may be changing.

  • Fashion Stocks Traders Love

      Over the past couple of months, the “Fast Money” traders weighed in on companies that stood out.

  • Best in Show

      Who is the top dog at the Westminster Kennel Club Dog Show

MOST SHARED


Current DateTime: 07:21:45 11 Feb 2012
LinksList Documentid: 31330905
Expiration DateTime: 2/11/2012 7:24:45 AM

MOST POPULAR


Current DateTime: 07:21:45 11 Feb 2012
LinksList Documentid: 35819650
    • Road Warriors

        All the gadgets and gear a savvy frequent traveler needs to navigate the global economy.

HOT ON FACEBOOK

Invitrogen to Buy Applied Biosystems for $6.7 Billion

Published: Thursday, 12 Jun 2008 | 9:37 AM ET
Text Size
By: Reuters

Invitrogen plans to buy Applied Biosystems in a deal valued at $6.7 billion to form a massive provider of research tools for the life sciences industry, the companies said on Thursday.

The purchase price of $38 per share in cash and stock represents a premium of 17 percent over Applied Biosystems' closing price on Wednesday and 12 percent over its average closing price over the past 30 days. The split is expected to be 45 percent cash and 55 percent Invitrogen stock.

The combined company will generate about $3.5 billion in combined sales, offering a wide variety of products in areas such as genetic analysis, proteomics, cell biology and cell systems.

Applied Biosystems' equipment includes mass spectrometers, which can measure the molecular weight of proteins and thereby identify them.

Invitrogen [IVGN  Loading...      ()   ] shares fell 10 percent after the deal announcement, while Applied Biosystems [ABI  Loading...      ()   ] rose 8 percent.

"In the most general terms, it makes sense in terms of their expertise in molecular biology, efficiencies in combined sales forces, overlap on product line and intellectual property interests," said Deutsche Bank analyst Ross Muken. Such a combination was a source of speculation at a conference in Denver last week, he added.

Upon closing, Invitrogen shareholders would own the majority of the merged company, which would be named Applied Biosystems.

Applied Biosystems is one of two tracking stocks of Applera, which announced the deal with Invitrogen. Celera Group [CRA  Loading...      ()   ] is the other.

The companies expect the merger to close in the fall and to be neutral to or slightly help earnings per share in the first year and significantly positive in the second year.

Invitrogen shares fell $4.35 to $39 in early electronic trading from a Wednesday close of $43.35 on Nasdaq.

Applied Biosystems shares rose to $35 from Wednesday's New York Stock Exchange close of $32.44.

Copyright 2011 Thomson Reuters. Click for restrictions.

CNBC HIGHLIGHTS

  • Alternative Investing: A CNBC Special Report
  • Marketing clichés aside, sometimes diamonds are for investing.
  • Nordstrom
  • The ‘Fast Money’ traders weigh in on fashion related stocks from apparel to footwear.
  • Las Vegas
  • This list of the 10 most active cities for speed traps was compiled by Trapster.com. See if your town is there.
  • This Valentine’s Day should prove a love fest for restaurants, as many couples will be dining out.
  • Airdale Terrier
  • Here’s a look at Westminster Kennel Club’s most successful breeds—and how much they cost.
  • Jennifer Aniston and Justin Theroux home
  • What kind of homes do celebrity couples share? Here’s our updated list. Take a look.


Current DateTime: 09:37:11 10 Feb 2012
LinksList Documentid: 29778428

Current DateTime: 02:33:42 10 Feb 2012
LinksList Documentid: 29779196

Current DateTime: 11:35:14 10 Feb 2012
LinksList Documentid: 29779197

Current DateTime: 02:56:31 10 Feb 2012
LinksList Documentid: 29779199
CNBCCNBC
About CNBC  |  Site Map  |  Video Reprints   |  Advertise  |  Help  |  Contact
Privacy Policy  |     |  Terms of Service  |  Independent Programming Report
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2012 CNBC LLC.  All Rights Reserved.
A Division of NBCUniversal
Thomson ReutersThomson Reuters